BEI
WST icon

Benjamin Edwards Inc’s West Pharmaceutical WST Stock Holding History

Benjamin Edwards Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Buy
5,322
+1,720
+48% +$526K 0.02% 587
2026
Q1 		$903K Buy
3,602
+194
+6% +$48.3K 0.01% 794
2025
Q4 		$938K Buy
3,408
+13
+0.4% +$3.56K 0.01% 737
2025
Q3 		$891K Buy
3,395
+374
+12% +$90.9K 0.01% 732
2025
Q2 		$661K Buy
3,021
+50
+2% +$10.7K 0.01% 759
2025
Q1 		$665K Buy
2,971
+1,038
+54% +$286K 0.01% 710
2024
Q4 		$633K Buy
1,933
+7
+0.4% +$2.2K 0.01% 757
2024
Q3 		$578K Buy
1,926
+1,373
+248% +$420K 0.01% 753
2024
Q2 		$182K Sell
553
-40
-7% -$14.1K 0.04% 351
2024
Q1 		$235K Buy
593
+23
+4% +$8.51K 0.05% 316
2023
Q4 		$201K Buy
570
+2
+0.4% +$708 0.04% 320
2023
Q3 		$213K Buy
568
+1
+0.2% +$387 0.05% 270
2023
Q2 		$217K Sell
567
-55
-9% -$19.6K 0.05% 263
2023
Q1 		$216K Buy
622
+77
+14% +$22.5K 0.05% 263
2022
Q4 		$128K Buy
545
+92
+20% +$21.8K 0.03% 326
2022
Q3 		$111K Buy
453
+18
+4% +$5.48K 0.03% 329
2022
Q2 		$132K Buy
435
+96
+28% +$31.2K 0.04% 302
2022
Q1 		$139K Buy
339
+335
+8,375% +$131K 0.04% 309
2021
Q4 		$2K Buy
+4
New +$1.72K ﹤0.01% 685

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Benjamin Edwards Inc's WST Position: Q2 2026 in Review

Benjamin Edwards Inc increased its West Pharmaceutical (WST) stake by 48% in Q2 2026, buying an estimated $526K and bringing the position to 5,322 shares worth $1.91M. The position accounts for 0.02% of the portfolio, ranked #587.

Benjamin Edwards Inc first reported a position in WST in Q4 2021 and has held it in 19 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Benjamin Edwards Inc held 5,322 shares of West Pharmaceutical worth $1.91M as of Q2 2026.
  • Benjamin Edwards Inc bought 1,720 West Pharmaceutical shares in Q2 2026, an estimated $526K.
  • West Pharmaceutical made up 0.02% of Benjamin Edwards Inc's portfolio in Q2 2026, its #587 holding.
  • Benjamin Edwards Inc first reported a position in West Pharmaceutical in Q4 2021 and has held it in 19 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.